Jump to main content
Jump to site search

Issue 4, 2011
Previous Article Next Article

Synthesis and evaluation of xylopyranoside derivatives as “decoy acceptors” of human β-1,4-galactosyltransferase 7

Author affiliations

Abstract

Proteoglycans (PGs), including heparan sulfate forms, are important regulators of tumor progression. In the PGs biosynthetic process, the core protein is synthesized on a ribosomal template and the sugar chains are assembled post-translationally, one sugar at a time, starting with the linkage of xylose to a serine residue of the core protein and followed by galactosidation of the xylosylprotein. Hydrophobic xylopyranosides have been previously shown to prime heparan sulfate synthesis, a property that was required to cause growth inhibition of tumor cells. To know if the antiproliferative activity of synthetic xylopyranosides is related to their ability to act as “decoy acceptors” of xylosylprotein 4-β-galactosyltransferase, we have heterologously expressed the catalytic domain of the human β-1,4-GalT 7 and studied the ability of a variety of synthetic xylopyranoside derivatives to act as substrates or inhibitors of the recombinant enzyme.

Graphical abstract: Synthesis and evaluation of xylopyranoside derivatives as “decoy acceptors” of human β-1,4-galactosyltransferase 7

Back to tab navigation

Supplementary files

Publication details

The article was received on 24 Sep 2010, accepted on 24 Jan 2011 and first published on 15 Feb 2011


Article type: Paper
DOI: 10.1039/C0MB00206B
Citation: Mol. BioSyst., 2011,7, 1312-1321
  •   Request permissions

    Synthesis and evaluation of xylopyranoside derivatives as “decoy acceptors” of human β-1,4-galactosyltransferase 7

    J. F. García-García, G. Corrales, J. Casas, A. Fernández-Mayoralas and E. García-Junceda, Mol. BioSyst., 2011, 7, 1312
    DOI: 10.1039/C0MB00206B

Search articles by author

Spotlight

Advertisements